Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-24-006859

CFO acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shin Barry CFO 2024-12-09 Grant or award +400,000 $1.65 $660,000 400,000 D
Derivatives
Shin Barry CFO 2024-12-09 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X05/ownership.xml…